Kymera Therapeutics Inc (KYMR) — Capital Reinvestment Ratio
Kymera Therapeutics Inc (KYMR) has a Capital Reinvestment Ratio of 1.44x as of December 2023, meaning it reinvests 1% of its operating cash flow ($8.04 Million) in capital expenditures ($11.62 Million). See Kymera Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kymera Therapeutics Inc Capital Reinvestment Ratio (2019–2020)
This chart tracks Kymera Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check KYMR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kymera Therapeutics Inc (2019–2020)
Year-by-year Capital Reinvestment Ratio for Kymera Therapeutics Inc from 2019 to 2020. For live market cap and broader valuation context, see Kymera Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.10x | $88.13 Million | $9.10 Million | ▲ +247.4% |
| 2019 | 0.03x | $17.91 Million | $532.00K | — |